TXMD 股价走势图
TXMD 股票价格预测
TherapeuticsMD Inc
$2.09
0.96%
$0.02
收盘价：Aug 06, 16:00:00 GMT-4
$2.05
-1.91%
$-0.04
盘后：Aug 06, 20:00:00 GMT-4
返回
TherapeuticsMD Inc (TXMD) 股票价格预测
关键数据
前收盘价
$2.07
开盘价
$2.03
当日区间
$2.03 - $2.11
52周范围
$0.99 - $2.95
交易量
10.1K
平均成交量
33.8K
股息收益率
--
每股收益（TTM）
0.02
市值
$23.7M
什么是 TXMD？
TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 1 full-time employees. The company went IPO on 2001-01-31. The company receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
